Current through Register Vol. 51, No. 24, December 2, 2024
Section 30.08.18.14 - Quality ManagementThe facility shall:
A. Participate, in a manner approved by the EMS Board, in a stroke registry that includes the data elements tracked by the Centers for Medicare and Medicaid Services and the American Heart/American Stroke Get With the Guidelines®-Stroke Registry;B. Have participated in the stroke registry and maintained a stroke log for a minimum of 6 months prior to time of requesting an application;C. Demonstrate ongoing participation in the stroke registry;D. Authorize the stroke registry to provide the hospital data to MIEMSS for health oversight activities in a manner approved by the EMS Board;E. Establish at least two outcome objectives that: (3) Reflect tracking and trending of performance measures and indicators; and(4) Are reviewed in annual comparison studies;F. Maintain a stroke log which includes at a minimum the following information for each entry:(1) The number of times the stroke team was activated;(2) The stroke team's response time to the acute stroke patient;(3) The on-call neurologist's response time for consultation to the acute stroke patient;(4) The type or types of diagnostic tests and acute treatment utilized;(5) The patient's diagnosis;(6) Door to IV fibrinolytic time;(7) Patient complications;(8) Arrival and departure/transfer times; and(9) Disposition of the patient;G. Monitor its IV fibrinolytic complications, which includes symptomatic intracerebral hemorrhage and serious life-threatening systemic bleeding;H. Establish at least one stroke center quality assurance medical review committee which shall be a medical review committee under Health Occupations Article, § 1-401, Annotated Code of Maryland, as a committee established in the Maryland Institute for Emergency Medical Services Systems which, at least three times a year: (2) Reviews practice patterns; and(3) Modifies practice patterns as appropriate;I. In cases where the administration of fibrinolytics is appropriate: (1) Administer the fibrinolytic within 60 minutes from the time the patient arrives at the emergency department for greater than or equal to 50 percent of eligible patients;(2) Demonstrate progress towards administering fibrinolytics within 60 minutes from the time the patient arrives at the emergency department for greater than or equal to 75 percent of eligible patients; and(3) Demonstrate progress towards reducing time of administration of fibrinolytics to 45 minutes for greater than or equal to 50 percent of eligible patients;J. Incorporate into their quality assurance process progress reports about:(1) Specific acute stroke treatment benchmarks;(2) Outcomes data on patients transferred for a higher level of care; and(3) Stroke treatment quality improvement goals; andK. Provide MIEMSS with documentation of quality management of the stroke program for review, including, if appropriate: (1) Problem identification;(4) Implementation of the plan; and(5) Re-evaluation of the plan.Md. Code Regs. 30.08.18.14
Regulation .14 adopted 48:9 Md. R. 360, eff. 7/1/2021